-
Signature
-
/s/ David M. Roberts, by Raphael Avraham, as Attorney-in-Fact
-
Stock symbol
-
VRRM
-
Transactions as of
-
Nov 14, 2023
-
Transactions value $
-
-$1,428,113
-
Form type
-
4
-
Date filed
-
11/16/2023, 05:00 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
VRRM |
Class A Common Stock |
Options Exercise |
$531K |
+38.8K |
+6.82% |
$13.69 |
607K |
Nov 14, 2023 |
Direct |
|
transaction |
VRRM |
Class A Common Stock |
Sale |
-$784K |
-38.8K |
-6.38% |
$20.22 |
568K |
Nov 14, 2023 |
Direct |
F1, F2 |
transaction |
VRRM |
Class A Common Stock |
Options Exercise |
$1.95M |
+154K |
+27.18% |
$12.62 |
723K |
Nov 14, 2023 |
Direct |
|
transaction |
VRRM |
Class A Common Stock |
Sale |
-$3.12M |
-154K |
-21.37% |
$20.22 |
568K |
Nov 14, 2023 |
Direct |
F1, F2 |
holding |
VRRM |
Class A Common Stock |
|
|
|
|
|
220K |
Nov 14, 2023 |
Trust |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
VRRM |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-154K |
-75% |
$0.00 |
51.5K |
Nov 14, 2023 |
Class A Common Stock |
154K |
$12.62 |
Direct |
F3 |
transaction |
VRRM |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-38.8K |
-25% |
$0.00 |
116K |
Nov 14, 2023 |
Class A Common Stock |
38.8K |
$13.69 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: